By 
A research team at Cedars-Sinai reports a protein associated with cancer growth may play a role in developing idiopathic pulmonary fibrosis, a fatal lung disease. Experimenting with human tissue samples and mice, it indicates that existing anti-cancer treatments inhibiting the PD-L1 protein are potential candidates for treating the disease.
Lead Research/Investigator
Dianhua Jiang, MD, PhD, professor of Medicine at Cedars-Sinai
Paul Noble, MD, professor of Medicine and chair of the Department of Medicine